(VIANEWS) – China Petroleum & Chemical (SNP), Companhia Siderurgica Nacional S.A. (SID), Pangaea Logistics Solutions Ltd. (PANL) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. China Petroleum & Chemical (SNP)

64.5% sales growth and 12.96% return on equity

China Petroleum & Chemical Corporation, an energy and chemical company, engages in oil and gas, and chemical operations in the People's Republic of China.

China Petroleum & Chemical’s sales growth this year is anticipated to be 39.6% and 7% for next year.

Year-on-year quarterly revenue growth grew by 43.1%, now sitting on 2.33T for the twelve trailing months.

Volume

Today’s last reported volume for China Petroleum & Chemical is 125815 which is 21.94% below its average volume of 161184.

China Petroleum & Chemical’s sales growth for the next quarter is 64.5%. The company’s growth estimates for the ongoing quarter and the next is 60.6% and 158%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.96%.

Volatility

China Petroleum & Chemical’s last day, last week, and last month’s current volatility was 0.41%, 0.77%, and 1.36%, respectively.

China Petroleum & Chemical’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.03% (day), 1.45% (last week), and 1.35% (last month), respectively.

China Petroleum & Chemical’s Stock Yearly Top and Bottom Value

China Petroleum & Chemical’s stock is valued at $51.57 at 01:22 EST, way under its 52-week high of $58.40 and way above its 52-week low of $38.18.

China Petroleum & Chemical’s Moving Average

China Petroleum & Chemical’s worth is above its 50-day moving average of $49.41 and above its 200-day moving average of $50.40.

2. Companhia Siderurgica Nacional S.A. (SID)

28.3% sales growth and 107.13% return on equity

Companhia Siderúrgica Nacional operates as an integrated steel producer in Brazil and Latin America.

Companhia Siderurgica Nacional S.A.’s sales growth this year is expected to be 85.8% and a negative 19.1% for next year.

Year-on-year quarterly revenue growth grew by 147.4%, now sitting on 45.81B for the twelve trailing months.

Volume

Today’s last reported volume for Companhia Siderurgica Nacional S.A. is 2996960 which is 32.73% below its average volume of 4455490.

Companhia Siderurgica Nacional S.A.’s sales growth for the next quarter is 28.3%. The company’s growth estimates for the present quarter and the next is 1375% and 200%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 107.13%.

Volatility

Companhia Siderurgica Nacional S.A.’s last day, last week, and last month’s current volatility was 1.62%, 1.52%, and 2.87%, respectively.

Companhia Siderurgica Nacional S.A.’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 4.10% (day), 3.23% (last week), and 4.30% (last month), respectively.

Companhia Siderurgica Nacional S.A.’s Stock Yearly Top and Bottom Value

Companhia Siderurgica Nacional S.A.’s stock is valued at $4.93 at 01:22 EST, way under its 52-week high of $10.33 and way higher than its 52-week low of $3.39.

Companhia Siderurgica Nacional S.A.’s Moving Average

Companhia Siderurgica Nacional S.A.’s worth is way under its 50-day moving average of $5.85 and way below its 200-day moving average of $7.86.

3. Pangaea Logistics Solutions Ltd. (PANL)

19.9% sales growth and 17.14% return on equity

Pangaea Logistics Solutions, Ltd., together with its subsidiaries, provides seaborne dry bulk logistics and transportation services to industrial customers worldwide.

Pangaea Logistics Solutions Ltd.’s sales growth this year is expected to be 31.5% and a negative 27.2% for next year.

Year-on-year quarterly revenue growth grew by 106.8%, now sitting on 487.14M for the twelve trailing months.

Volume

Today’s last reported volume for Pangaea Logistics Solutions Ltd. is 234449 which is 44.79% below its average volume of 424726.

Pangaea Logistics Solutions Ltd.’s sales growth for the next quarter is 19.9%. The company’s growth estimates for the present quarter and the next is 147.1% and 94.1%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 17.14%.

Volatility

Pangaea Logistics Solutions Ltd.’s last day, last week, and last month’s current volatility was 2.36%, 2.54%, and 3.41%, respectively.

Pangaea Logistics Solutions Ltd.’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 5.43% (day), 5.23% (last week), and 5.88% (last month), respectively.

Pangaea Logistics Solutions Ltd.’s Stock Yearly Top and Bottom Value

Pangaea Logistics Solutions Ltd.’s stock is valued at $5.08 at 01:22 EST, way below its 52-week high of $6.20 and way higher than its 52-week low of $2.39.

Pangaea Logistics Solutions Ltd.’s Moving Average

Pangaea Logistics Solutions Ltd.’s value is below its 50-day moving average of $5.14 and way above its 200-day moving average of $4.38.

4. FVCBankcorp (FVCB)

12.9% sales growth and 9.31% return on equity

FVCBankcorp, Inc. operates as the holding company for FVCbank that provides various banking products and services in Virginia.

FVCBankcorp’s sales growth this year is expected to be 15.1% and 13.3% for next year.

Year-on-year quarterly revenue growth grew by 25.3%, now sitting on 53.49M for the twelve trailing months.

Volume

Today’s last reported volume for FVCBankcorp is 10 which is 99.96% below its average volume of 30426.

FVCBankcorp’s sales growth for the next quarter is 12.9%. The company’s growth estimates for the present quarter and the next is 32.1% and 8.3%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.31%.

Volatility

FVCBankcorp’s last day, last week, and last month’s current volatility was 0.15%, 0.57%, and 0.92%, respectively.

FVCBankcorp’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 3.07% (day), 1.85% (last week), and 1.92% (last month), respectively.

FVCBankcorp’s Stock Yearly Top and Bottom Value

FVCBankcorp’s stock is valued at $20.25 at 01:22 EST, under its 52-week high of $20.95 and way above its 52-week low of $10.80.

FVCBankcorp’s Moving Average

FVCBankcorp’s worth is higher than its 50-day moving average of $19.78 and above its 200-day moving average of $18.48.

5. Genpact Limited (G)

9.8% sales growth and 20.25% return on equity

Genpact Limited provides business process outsourcing and information technology (IT) services North and Latin America, India, rest of Asia, and Europe.

Genpact Limited’s sales growth this year is expected to be 7.6% and 9.7% for next year.

Year-on-year quarterly revenue growth grew by 9.8%, now sitting on 3.82B for the twelve trailing months.

Volume

Today’s last reported volume for Genpact Limited is 429240 which is 41.35% below its average volume of 731972.

Genpact Limited’s sales growth for the next quarter is 9.8%. The company’s growth estimates for the present quarter and the next is a negative 0% and 13.7%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 20.25%.

Volatility

Genpact Limited’s last day, last week, and last month’s current volatility was 0.96%, 0.64%, and 0.87%, respectively.

Genpact Limited’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.35% (day), 1.66% (last week), and 1.81% (last month), respectively.

Genpact Limited’s Stock Yearly Top and Bottom Value

Genpact Limited’s stock is valued at $48.20 at 01:22 EST, below its 52-week high of $52.75 and way above its 52-week low of $33.91.

Genpact Limited’s Moving Average

Genpact Limited’s value is below its 50-day moving average of $49.55 and above its 200-day moving average of $47.43.

6. NeoGenomics (NEO)

7.7% sales growth and 7.96% return on equity

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia.

NeoGenomics’s sales growth this year is expected to be 12.4% and 16.2% for next year.

Year-on-year quarterly revenue growth grew by 39.9%, now sitting on 488.7M for the twelve trailing months.

Volume

Today’s last reported volume for NeoGenomics is 1043540 which is 15.36% above its average volume of 904590.

NeoGenomics’s sales growth for the next quarter is 7.7%. The company’s growth estimates for the ongoing quarter and the next is a negative 233.3% and negative -150%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.96%.

Volatility

NeoGenomics’s last day, last week, and last month’s current volatility was 7.04%, 4.99%, and 3.39%, respectively.

NeoGenomics’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 8.36% (day), 5.94% (last week), and 5.21% (last month), respectively.

NeoGenomics’s Stock Yearly Top and Bottom Value

NeoGenomics’s stock is valued at $41.76 at 01:22 EST, way under its 52-week high of $61.57 and way higher than its 52-week low of $36.00.

NeoGenomics’s Moving Average

NeoGenomics’s worth is way below its 50-day moving average of $47.90 and under its 200-day moving average of $45.28.

7. LCNB Corporation (LCNB)

6.9% sales growth and 8.6% return on equity

LCNB Corp. operates as the financial holding company for LCNB National Bank that provides banking services in Ohio.

LCNB Corporation’s sales growth this year is expected to be 30.6% and 1.4% for next year.

Year-on-year quarterly revenue growth grew by 8.1%, now sitting on 72.44M for the twelve trailing months.

Volume

Today’s last reported volume for LCNB Corporation is 15032 which is 48.49% below its average volume of 29184.

LCNB Corporation’s sales growth for the next quarter is 6.9%. The company’s growth estimates for the ongoing quarter and the next is 30.3% and negative -6.8%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.6%.

Volatility

LCNB Corporation’s last day, last week, and last month’s current volatility was 0.23%, 0.62%, and 0.83%, respectively.

LCNB Corporation’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.66% (day), 1.38% (last week), and 1.74% (last month), respectively.

LCNB Corporation’s Stock Yearly Top and Bottom Value

LCNB Corporation’s stock is valued at $17.72 at 01:22 EST, way below its 52-week high of $19.99 and way above its 52-week low of $12.51.

LCNB Corporation’s Moving Average

LCNB Corporation’s worth is above its 50-day moving average of $17.31 and above its 200-day moving average of $17.36.

8. Royalty Pharma (RPRX)

6.2% sales growth and 19.76% return on equity

Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States.

Royalty Pharma’s sales growth this year is expected to be 5.6% and 3.5% for next year.

Year-on-year quarterly revenue growth grew by 8.6%, now sitting on 2.24B for the twelve trailing months.

Volume

Today’s last reported volume for Royalty Pharma is 1820040 which is 22.1% below its average volume of 2336460.

Royalty Pharma’s sales growth for the next quarter is 6.2%. The company’s growth estimates for the current quarter and the next is 41.7% and 171.4%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 19.76%.

Volatility

Royalty Pharma’s last day, last week, and last month’s current volatility was 3.43%, 1.26%, and 1.51%, respectively.

Royalty Pharma’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 3.14% (day), 2.26% (last week), and 2.52% (last month), respectively.

Royalty Pharma’s Stock Yearly Top and Bottom Value

Royalty Pharma’s stock is valued at $38.39 at 01:22 EST, way under its 52-week high of $53.23 and way above its 52-week low of $34.80.

Royalty Pharma’s Moving Average

Royalty Pharma’s worth is higher than its 50-day moving average of $37.42 and under its 200-day moving average of $40.40.

Previous days news about Royalty Pharma(RPRX)

  • Royalty pharma declares fourth-quarter 2021 dividend. According to Benzinga on Friday, 15 October, "NEW YORK, Oct. 15, 2021 (GLOBE NEWSWIRE) — The board of directors of Royalty Pharma plc (NASDAQ:RPRX) has approved the payment of a dividend for the fourth quarter of 2021 of $0.17 per Class A ordinary share.", "Founded in 1996, Royalty Pharma is the largest buyer of biopharmaceutical royalties and a leading funder of innovation across the biopharmaceutical industry, collaborating with innovators from academic institutions, research hospitals and not-for-profits through small- and mid-cap biotechnology companies to leading global pharmaceutical companies. "

LEAVE A REPLY

Please enter your comment!
Please enter your name here